Evidence map›Paper›PMID 26154066›Full record

ArticleAIDS patient care and STDs2015

Half of 30-Day Hospital Readmissions Among HIV-Infected Patients Are Potentially Preventable.

Ank E Nijhawan, Ellen Kitchell, Sarah Shelby Etherton, Piper Duarte, Ethan A Halm, Mamta K Jain

Open access · greenAbstract read
In one paragraph

Article in AIDS patient care and STDs, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Influence of CMO pharmaceutical care model-based intervention on readmission rate in high risk HIV patients: the INFARDAR study.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2021
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Hospitalization Rates and Outcomes Among Persons Living With Human Immunodeficiency Virus in the Southeastern United States, 1996-2016.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  13. Article
  14. Article
  15. COVID-19: What Is Next for Portugal?Frontiers in public health · 2020
    Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ank E Nijhawan1 Department of Medicine/Division of Infectious Diseases, University of Texas Southwestern Medical Center , Dallas, Texas.
Ellen Kitchell1 Department of Medicine/Division of Infectious Diseases, University of Texas Southwestern Medical Center , Dallas, Texas.
Sarah Shelby Etherton2 South End Associates Fenway Health , Boston, Massachusetts.
Piper Duarte3 Performance Improvement Analyst HIV Services, Parkland Health and Hospital Systems , Dallas, Texas.
Ethan A Halm4 Department of Internal Medicine/Clinical Sciences, University of Texas Southwestern Medical Center , Dallas, Texas.
Mamta K Jain1 Department of Medicine/Division of Infectious Diseases, University of Texas Southwestern Medical Center , Dallas, Texas.
The University of Texas Southwestern Medical Center · USFenway Health · USParkland Health & Hospital System · US

Funding

UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5M
UT Southwestern Center of Patient-Centered Outcomes Research (PCOR)R24HS022418 · AHRQ · UT SOUTHWESTERN MEDICAL CENTER · PI HALM, ETHAN A · 2013 to 2017
$5.0M
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1KL2TR001103 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$4.0M
Reducing Readmissions and Improving Outcomes in HIV-Infected PatientsK23AI112477 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI NIJHAWAN, ANK ELISABETH · 2015 to 2018
$703k
AHRQ HHS 1R24HS022418NCATS NIH HHS KL2 TR001103NCATS NIH HHS KL2TR001103NCATS NIH HHS UL1 TR001105NIAID NIH HHS K23 AI112477NIAID NIH HHS K23AI112477
6 · The paper itself

Abstract

Thirty-day readmission rates, a widely utilized quality metric, are high among HIV-infected individuals. However, it is unknown how many 30-day readmissions are preventable, especially in HIV patients, who have been excluded from prior potentially preventable readmission analyses. We used electronic medical records to identify all readmissions within 30 days of discharge among HIV patients hospitalized at a large urban safety net hospital in 2011. Two independent reviewers assessed whether readmissions were potentially preventable using both published criteria and detailed chart review, how readmissions might have been prevented, and the phase of care deemed suboptimal (inpatient care, discharge planning, post-discharge). Of 1137 index admissions, 213 (19%) resulted in 30-day readmissions. These admissions occurred among 930 unique HIV patients, with 130 individuals (14%) experiencing 30-day readmissions. Of these 130, about half were determined to be potentially preventable using published criteria (53%) or implicit chart review (48%). Not taking antiretroviral therapy (ART) greatly increased the odds of a preventable readmission (OR 5.9, CI:2.4-14.8). Most of the preventable causes of readmission were attributed to suboptimal care during the index hospitalization. Half of 30-day readmission in HIV patients are potentially preventable. Increased focus on early ART initiation, adherence counseling, management of chronic conditions, and appropriate timing of discharge may help reduce readmissions in this vulnerable population.

Indexed as

AdultAgedElectronic Health RecordsFemaleHIV InfectionsHumansMaleMiddle AgedOutcome Assessment, Health CarePatient DischargePatient ReadmissionRetrospective StudiesSocioeconomic FactorsTexasTime FactorsUrban Population

Identifiers

PMID26154066
PMCPMC4564018
OpenAlexW1853163122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.